精神在线您现在的位置:  >> NaSSA合理应用文献研究平台 >> 文献服务 >> 抗抑郁剂与性功能障碍的研究 >> 临床研究 >> 文献正文
抑郁症患者5-HT2AR基因启动子区-1438G/A基因型和G 蛋白β3亚单位基因C825T 多态性和SSRI相关性功能障碍
文献服务】【告诉好友】【打印此文】【关闭窗口
题目(Title)Serotonin 2A -1438 G/A and G-Protein Beta3 Subunit C825T Polymorphisms in Patients with Depression and SSRI-Associated Sexual Side-Effects

著者(Authors)】 Jeffrey R Bishop1, Jessica Moline2, Vicki L Ellingrod2, Susan K Schultz3 and Anita H Clayton4
来源(Source)】 University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA.
关键词(Keywords)】 .

摘要(Abstract)】:
The occurrence of sexual side-effects from antidepressants is thought to be mediated through serotonin 2A (5HT2A) receptors. It is currently unknown if functional polymorphisms in the 5HT2A receptor or its G-protein second messenger complex are related to sexual dysfunction in patients taking an selective serotonin reuptake inhibitor (SSRI) for depression. The purpose of this study was to determine the relationship of the 5HT2A -1438 G/A and GNB3 C825T single nucleotide polymorphisms with overall sexual well-being and individual components of sexual health as measured by the Changes in Sexual Functioning Questionnaire (CSFQ). We evaluated 89 outpatients (18-40 years of age) at low risk for other causes of sexual dysfunction who were being treated for depression with an SSRI and did not have sexual difficulties before taking the antidepressant. Outcome measures were stratified by 5HT2A and GNB3 genotypes. After controlling for age, gender, anxiety scale scores, and depression scale scores, persons with a GG genotype of the 5HT2A -1438 single nucleotide polymorphisms (SNP) were significantly more likely to be categorized as having sexual dysfunction than persons with a GA or AA genotype (OR=3.6; 95% CI 1.03, 12.6; p=0.046). Furthermore, the 5HT2A -1438 GG genotype was a significant predictor of lower arousal scores (p=0.022) after accounting for other measures. There was no significant relationship between any outcome measure and GNB3 genotype.

  • 上一篇文献:
  • 下一篇文献:

  • 相关文献
    服用SSRI类抗抑郁药治疗慢性抑郁症的患者性功能:一项初步研究
    米氮平,育亨宾或奥氮平补充治疗5-羟色氨再摄取相关的女性性功能障碍-一项随机安慰剂对照试验
    Rush性调查表评价SSRI类治疗后出现的性功能改变
    完全睡眠剥夺联合抗抑郁药治疗对老年抑郁症患者脑部糖代谢的影响
    伴有失眠症状的抑郁症患者的抗抑郁药物治疗
    一项三重病例回顾突出了米氮平在减少焦虑症,情绪激动,失眠,抑郁症,性功能障碍治疗中多重用药的临床及药理应用
    助眠与失眠
    老年失眠症的病因、评估方法及治疗
    失眠与焦虑障碍和抑郁症的联系--易患因素探查
    米氮平对睡眠的作用--一项由青年健康志愿者参加的安慰剂双盲对照研究
    米氮平,混合5-羟色胺受体激动剂抑制剂,抑制小鼠睡眠呼吸暂停综合征
    米氮平治疗睡眠呼吸暂停综合征的疗效
    比较行为--认知行为与药物治疗慢性失眠后的睡眠状况和睡眠相关心理活动
    一项初步研究:米氮平对抑郁症病人睡眠连续性和睡眠结构的急性效应
    老年抑郁症患者完全睡眠剥夺和睡眠复苏的临床反应:抗抑郁药物治疗结果的潜在暗示
    抑郁症治疗的不同阶段主观和客观睡眠量度的相关性
    睡眠剥夺的临床神经递质启示



    精神在线网 复旦大学医学院精神卫生学系 合办
    本站专业医学信息和服务仅供中国医疗专业人士参考

    © 精神在线网 PsyCard.Com
    精神/心理医学专业信息网络平台、博客、论坛
    全站文章索引-SiteMap